New syrup aims to soothe coughs in just two days
NCT ID NCT07625683
First seen Jun 04, 2026 · Last updated Jun 20, 2026 · Updated 4 times
Summary
This study looks at how well and how safely SIROPSEDAL syrup works for acute cough caused by colds or upper respiratory infections. About 124 children and adults will take the syrup as prescribed by their doctor and report their cough severity over one week. The main goal is to see if most people feel a meaningful reduction in cough by the second day.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER RESPIRATORY TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Multiples facilities
Multiple Locations, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SIROPSEDAL (a syrup for cough)
What this could lead to
If it works, this could confirm that SIROPSEDAL effectively reduces cough intensity within two days for people with acute cough from colds or respiratory infections.
What could go wrong
This is an observational study without a placebo group, so results may be less reliable. It is also small (124 people) and only follows participants for one week, so long-term effects or comparisons to other treatments are unknown.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.